Optimizing Clinical Outcomes by Optimizing the Management of Hyperlipidemia is organized by C3-Interventional Academy.

Release Date: Oct 23, 2019
Expiration Date: Oct 23, 2020

Ciné-Med assigns this enduring online CME material for a maximum of 1.5 AMA PRA Category 1Credit(s)™. Physicians can acquire credit commensurate based on the extent of their participation in the conference.

Educational Objectives:
At the conclusion of this online CME session, learners should be able to:
• specify the relationship between LDL-C and cardiovascular disease as well as the substantial residual risk among patients receiving statin therapy.
• Discuss PCSK9 inhibition as a unique mechanism to reduce LDL-C and improve cardiovascular outcomes.
• Know the influence of PCSK9 inhibitors on coronary plaque, clinical outcomes, and safety, in particular neurocognitive events.
• Explain recent ACC/AHA guidelines for the management of hyperlipidemia in the context of clinical cases.

Additional details will be posted as soon as information is available.






Diabetes Type 1: Current Approaches in Patient Management for Individuals Diagnosed with Type 1 Diabetes
Oct 06, 2022 - Jun 02, 2025 | Text-Based CME
Endocrinology, Metabolism and Diabetes
2.5 Contact Hours
More actions
Chronic Obstructive Pulmonary Disease (COPD): Patient Management
Feb 12, 2020 - May 01, 2025 | Text-Based CME
6 Contact Hours
More actions
Risk Stratification of a Pulmonary Embolism: What You Need to Know and Why
May 21, 2021 - May 21, 2024 | Text-Based CME
1.5 Contact Hours
More actions